SCHEMBL8767903

SCHEMBL8767903

O=C(O)NCC=CF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1897647 0.76
SCHEMBL4241010 0.76
SCHEMBL11507953 0.74
SCHEMBL3991216 0.74
SCHEMBL3557899 0.74
SCHEMBL23933262 0.74
SCHEMBL9395924 0.74
SCHEMBL3991223 0.74
SCHEMBL5620333 0.74
SCHEMBL3557900 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0611367-B1 NOVEL UV CURABLE CROSSLINKING AGENTS USEFUL IN COPOLYMERIZATION BAUSCH & LOMB (US) 1997-06-25 EP claimed
US-12428370-B2 Haloallylamine dual amine oxidase inhibitors SYNTARA LIMITED (AU) 2025-09-30 US disclosed
CN-111886233-B Triazolone derivatives or salts thereof and pharmaceutical compositions containing the same 柳韩洋行 2024-01-02 CN disclosed
US-20230257342-A1 HALOALLYLAMINE DUAL AMINE OXIDASE INHIBITORS PHARMAXIS LTD. (AU) 2023-08-17 US disclosed
EP-4171740-A1 HALOALLYLAMINE DUAL AMINE OXIDASE INHIBITORS Pharmaxis Ltd. (AU) 2023-05-03 EP disclosed